RANI - Rani Therapeutics GAAP EPS of -$0.29 beats by $0.03 May, 11 2022 04:47 PM Rani Therapeutics Holdings Inc. Rani Therapeutics press release (NASDAQ:RANI): Q1 GAAP EPS of -$0.29 beats by $0.03. Cash and cash equivalents of $107.84M For further details see: Rani Therapeutics GAAP EPS of -$0.29 beats by $0.03